Lactate Biomarker May Predict Outcomes in Cardiogenic Shock - Top-Institutions - MDSpire

Lactate Biomarker May Predict Outcomes in Cardiogenic Shock

A review of cardiogenic shock studies suggests serial lactate measurements provide more prognostic information than isolated values and may better reflect treatment response.

  • By

  • Andrea Surnit

  • June 23, 2026

  • 4 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Université de Lorraine
    Université de Lorraine

    Nancy, Grand Est

    Key Differentiators

    • Cardiology

  • #2

    Centre Hospitalier Régional Universitaire de Nancy
    Centre Hospitalier Régional Universitaire de Nancy

    Nancy, Grand Est

    Key Differentiators

    • Cardiology

  • #3

    MIMIC-IV
    MIMIC-IV

    Boston, Massachusetts

    Key Differentiators

    • Critical Care

  • #4

    Guizhou Medical University Affiliated Hospital
    Guizhou Medical University Affiliated Hospital

    Guiyang, Guizhou

    Key Differentiators

    • Critical Care

  • #5

    Fundación Valle del Lili
    Fundación Valle del Lili

    Cali, Valle del Cauca

    Key Differentiators

    • Cardiology

Original Source(s)

Lactate Biomarker May Predict Outcomes in Cardiogenic Shock

  • by Andrea Surnit

  • June 23, 2026

Related Content

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.

Top 10 FDA Recalls Physicians Should Know

A structured overview of recent FDA recalls, corrections, and alerts involving medications, ventilators, insulin delivery systems, cardiovascular devices, anesthesia products, and other equipment used in clinical practice.

Elevated angiography-derived microvascular resistance and HbA1c levels jointly predict adverse outcomes in patients with diabetic STEMI: a multicenter retrospective cohort study